NERV Minerva Neurosciences, Inc - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$4.95
Price · Aug 19, 2026
Fundamentals as of Aug 7, 2026

About Minerva Neurosciences, Inc - Common Stock Company overview from Wikipedia

NERV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$4.95
Market Cap
$217M
P/E (TTM)
-0.1
EPS (TTM)
$-34.67
Revenue (TTM)
$0
Div Yield
ROE
339.5%
Debt/Equity
52W Range
$2 – $12

NERV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $0
7-point trend, +0.00
2017-12-31 2024-12-31
EPS $-34.67
7-point trend, -1774.1%
2019-12-31 2025-12-31
Free Cash Flow
2017-12-31 2017-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NERV
Peer Median
P/E (TTM)
5-point trend, +83.1%
-0.1
P/B
5-point trend, -105.3%
-1.5
1.4

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NERV
Peer Median
ROA
5-point trend, -1297.5%
-434.3%
-58.9%
ROE
5-point trend, +748.5%
339.5%
-83.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NERV
Peer Median
Current Ratio
5-point trend, +45.5%
36.3
8.5
Quick Ratio
5-point trend, +47.4%
35.9

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NERV
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NERV
Peer Median
EPS (Diluted)
5-point trend, -270.8%
$-34.67

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NERV
Peer Median

NERV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 9 analysts
  • Strong Buy 2 22.2%
  • Buy 4 44.4%
  • Hold 3 33.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-19
Median target $10.00 +102.2%
Mean target $10.33 +109.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.19%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.17 $-0.12 -0.05%
March 31, 2026 $-0.17 $-0.13 -0.04%
Dec. 31, 2025 $-0.64 $-0.31 -0.33%
June 30, 2025 $-0.43 $-0.92 0.49%
March 31, 2025 $-0.50 $-1.09 0.59%
Dec. 31, 2024 $-0.56 $-1.07 0.51%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
NERV $174M -0.1 339.5%
ORGO $658M 34.5 17.0% 6.6% 13.9%
AKBA $427M -80.5 47.5% -2.3% -17.3%
DTIL $100M -1.2 -50.1% -133.4% -72.4%
TARA $286M -4.0 -33.7%
RNA $10.91B -14.5 72.1% -3650.4% -47.5%
CNXU
IMUX -0.9
TNXP $200M -1.1 29.8% -946.2% -60.0%
NBP
ABOS $128M -1.1 -129.4%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for NERV
Metric Trend 202520242023202220212020201920182017
Revenue 7-point trend, +0.00 · $0 $0 $0 · $41M $0 $0 $0
R&D Expense 9-point trend, -81.0% $6M $12M $13M $15M $32M $22M $58M $35M $30M
SG&A Expense 9-point trend, -14.4% $9M $10M $10M $11M $13M $17M $18M $17M $11M
Operating Expenses 9-point trend, -63.3% $15M $22M $23M $25M $45M $39M $76M $52M $41M
Operating Income 9-point trend, +63.3% $-15M $-22M $-23M $-25M $-45M $2M $-76M $-52M $-41M
Interest Income 9-point trend, +0.7% $948.1K $1M $1M $556.9K $16.5K $161.2K $1M $2M $941.8K
Pretax Income 6-point trend, +21.5% · · · $-32M $-52M $2M $-74M $-50M $-41M
Income Tax 4-point trend, +80.8% · · · · $-2M · $-2M $0 $-9M
Net Income 9-point trend, -830.8% $-293M $1M $-30M $-32M $-50M $2M $-72M $-50M $-32M
EPS (Basic) 7-point trend, -1774.1% $-34.67 $0.19 $-4.61 $-6.01 $-9.35 $0.05 $-1.85 · ·
EPS (Diluted) 7-point trend, -1774.1% $-34.67 $0.19 $-4.61 $-6.01 $-9.35 $0.05 $-1.85 · ·
Shares (Basic) 7-point trend, -78.3% 8,463,581 7,568,981 6,506,372 5,340,194 5,340,196 40,823,717 39,014,302 · ·
Shares (Diluted) 7-point trend, -78.3% 8,463,581 7,573,763 6,506,372 5,340,194 5,340,196 40,916,871 39,014,302 · ·
EBITDA 6-point trend, +63.3% $-15M · · · $-45M $2M $-76M $-52M $-41M
Balance Sheet 22
Annual Balance Sheet data for NERV
Metric Trend 202520242023202220212020201920182017
Cash & Equivalents 9-point trend, +215.9% $82M $21M $41M $36M $61M $25M $21M $50M $26M
Short-term Investments 3-point trend, -76.1% · · · · · · $24M $38M $102M
Prepaid Expense 9-point trend, -46.3% $697.7K $806.9K $989.9K $848.1K $1M $2M $1M $2M $1M
Current Assets 9-point trend, -35.9% $83M $22M $42M $40M $62M $27M $47M $90M $130M
PP&E (Net) 7-point trend, -100.0% $0 $5.4K $10.9K $16.3K · · $16.0K $33.5K $50.9K
Goodwill Flat — no change across 9 periods $15M $15M $15M $15M $15M $15M $15M $15M $15M
Intangibles 4-point trend, -55.6% · · · · · $15M $15M $34M $34M
Other Non-current Assets Flat — no change across 4 periods · · · · · $14.8K $14.8K $14.8K $14.8K
Total Assets 9-point trend, -46.7% $98M $37M $57M $55M $77M $58M $77M $139M $184M
Accounts Payable 9-point trend, -55.4% $639.7K $2M $2M $969.7K $2M $995.6K $2M $2M $1M
Short-term Debt · · · · · · · · $4M
Current Liabilities 9-point trend, -66.5% $2M $3M $3M $1M $3M $3M $7M $4M $7M
Capital Leases · · · · · · $111.2K · ·
Deferred Tax 4-point trend, -55.6% · · · · · $2M $2M $4M $4M
Other Non-current Liabilities 2-point trend, -3.0% · · · · · · · $29.0K $29.9K
Total Liabilities 9-point trend, +348.7% $234M $63M $85M $75M $69M $5M $50M $49M $52M
Total Debt · · · · · · · · $4M
Common Stock 9-point trend, +11.7% $4.3K $699 $699 $534 $534 $4.3K $3.9K $3.9K $3.9K
Retained Earnings 9-point trend, -319.0% $-689M $-395M $-397M $-367M $-335M $-285M $-287M $-215M $-164M
Stockholders' Equity 9-point trend, -207.0% $-141M $-26M $-28M $-20M $8M $53M $28M $90M $132M
Liabilities + Equity 9-point trend, -46.7% $98M $37M $57M $55M $77M $58M $77M $139M $184M
Shares Outstanding 9-point trend, +11.7% 43,274,398 6,993,406 6,993,406 5,340,193 5,340,196 5,340,196 39,084,121 38,937,971 38,749,343
Cash Flow 12
Annual Cash Flow data for NERV
Metric Trend 202520242023202220212020201920182017
D&A 7-point trend, -50.9% $5.4K $5.4K $5.4K · · $16.0K $17.5K $17.5K $11.1K
Stock-based Comp 9-point trend, -73.6% $1M $1M $2M $4M $5M $10M $9M $8M $5M
Other Non-cash 4-point trend, -253.8% · · · · · $-45M $20M $29.4K $30M
Operating Cash Flow 9-point trend, -536.8% $-14M $-20M $-15M $-25M $-25M $-34M $-43M $-42M $3M
CapEx 2-point trend, -68.8% · · · $16.3K · · · · $52.4K
Investing Cash Flow 8-point trend, +100.0% $0 $0 $0 $-16.3K · $25M $14M $69M $-107M
Stock Repurchased · · · · · · · · $389
Net Stock Activity · · · · · · · · $-389
Financing Cash Flow 8-point trend, +57.8% $74M · $20M $-5 $60M $13M $525.0K $-3M $47M
Net Change in Cash 9-point trend, +207.0% $61M $-20M $5M $-25M $35M $4M $-29M $24M $-57M
Taxes Paid Flat — no change across 2 periods $0 $0 · · · · · · ·
Free Cash Flow · · · · · · · · $3M
Profitability 7
Annual Profitability data for NERV
Metric Trend 202520242023202220212020201920182017
Operating Margin · · · · · 4.5% · · ·
Net Margin · · · · · 4.7% · · ·
Pretax Margin · · · · · 4.7% · · ·
EBITDA Margin · · · · · 4.5% · · ·
ROA 6-point trend, -2081.5% -434.3% · · · -74.1% 2.9% -66.6% -31.1% -19.9%
ROE 6-point trend, +1509.9% 339.5% · · · -276.8% 3.5% -173.3% -52.3% -24.1%
ROIC 4-point trend, -2245.0% · · · · -549.0% · -264.8% -57.3% -23.4%
Liquidity & Solvency 3
Annual Liquidity & Solvency data for NERV
Metric Trend 202520242023202220212020201920182017
Current Ratio 6-point trend, +91.5% 36.3 · · · 22.1 8.7 7.1 24.9 18.9
Quick Ratio 6-point trend, +91.7% 35.9 · · · 21.6 8.0 6.9 24.4 18.7
Debt / Equity · · · · · · · · 0.0
Efficiency 1
Annual Efficiency data for NERV
Metric Trend 202520242023202220212020201920182017
Asset Turnover 4-point trend, +0.61 · · · · · 0.6 0.0 0.0 0.0
Per Share 5
Annual Per Share data for NERV
Metric Trend 202520242023202220212020201920182017
Book Value / Share 6-point trend, -195.8% $-3.25 · · · $0.19 $1.23 $0.71 $2.32 $3.40
Revenue / Share · · · · · $1.01 · · ·
Cash Flow / Share 3-point trend, -93.1% $-1.60 · · · $-0.58 $-0.83 · · ·
Cash / Share 6-point trend, +182.9% $1.90 · · · $1.42 $0.59 $0.55 $1.29 $0.67
EPS (TTM) 7-point trend, -1774.1% $-34.67 $0.19 $-4.61 $-6.01 $-9.35 $0.05 $-1.85 · ·
Valuation (TTM) 13
Annual Valuation (TTM) data for NERV
Metric Trend 202520242023202220212020201920182017
Revenue TTM 7-point trend, +0.00 · $0 $0 $0 · $41M $0 $0 $0
Net Income TTM 9-point trend, -830.8% $-293M $1M $-30M $-32M $-50M $2M $-72M $-50M $-32M
Market Cap 6-point trend, -90.7% $174M · · · $274M $800M $2.22B $2.10B $1.88B
Enterprise Value · · · · · · · · $1.75B
P/E 7-point trend, +99.6% -0.1 11.7 -1.3 -0.3 -0.7 374.4 -30.7 · ·
P/S · · · · · 19.4 · · ·
P/B 6-point trend, -108.7% -1.2 · · · 34.3 15.2 80.0 23.3 14.3
P / Tangible Book · · · · · 35.4 · · ·
P / Cash Flow 6-point trend, -102.1% -12.9 · · · -11.1 -23.6 -51.2 -50.1 606.4
P / FCF · · · · · · · · 616.8
EV / EBITDA · · · · · · · · -42.5
EV / FCF · · · · · · · · 576.0
Earnings Yield 7-point trend, -26436.6% -862.4% 8.6% -75.0% -378.0% -145.9% 0.27% -3.2% · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $0$0$0
Net Income $-293M$1M$-30M$-32M$-50M
Diluted EPS $-34.67$0.19$-4.61$-6.01$-9.35
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 36.322.1
Quick Ratio 35.921.6

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 60 filers · $216.5M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
27 (+9 vs prior Q) 8 (+5 vs prior Q) 10 (+2 vs prior Q) 11 (+3 vs prior Q) -1.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
FEDERATED HERMES, INC. $25,920,864 4,670,426 11.97% Shares
JANUS HENDERSON GROUP PLC $25,872,910 4,294,259 11.95% Shares
Vivo Capital, LLC $23,991,246 4,322,747 11.08% Shares
Balyasny Asset Management L.P. $23,626,350 4,257,000 10.91% Shares
Logos Global Management LP $18,252,712 3,288,777 8.43% Shares
FARALLON CAPITAL MANAGEMENT, L.L.C. $13,125,750 2,365,000 6.06% Shares
Ally Bridge Group (NY) LLC $12,075,701 2,175,802 5.58% Shares
Foresite Capital Management VI LLC $11,019,991 1,985,584 5.09% Shares
VANGUARD CAPITAL MANAGEMENT LLC $10,505,079 1,892,807 4.85% Shares
Spruce Street Capital LP $9,188,025 1,655,500 4.24% Shares
Trails Edge Capital Partners, LP $7,875,450 1,419,000 3.64% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $7,875,450 1,419,000 3.64% Shares
GEODE CAPITAL MANAGEMENT, LLC $4,590,644 826,794 2.12% Shares
DV EQUITIES, LLC $4,186,903 754,397 1.93% Shares
ACUTA CAPITAL PARTNERS, LLC $3,937,725 709,500 1.82% Shares
MILLENNIUM MANAGEMENT LLC $2,961,491 533,602 1.37% Shares
STATE STREET CORP $2,358,278 424,915 1.09% Shares
VANGUARD FIDUCIARY TRUST CO $1,679,452 302,604 0.78% Shares
Seven Fleet Capital Management LP $1,370,717 246,976 0.63% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $1,302,885 234,754 0.60% Shares
GOLDMAN SACHS GROUP INC $798,945 143,954 0.37% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $630,619 113,625 0.29% Shares
RENAISSANCE TECHNOLOGIES LLC $406,815 73,300 0.19% Shares
Y-Intercept (Hong Kong) Ltd $359,013 64,687 0.17% Shares
Walleye Capital LLC $299,128 53,897 0.14% Shares
Nuveen, LLC $252,403 45,478 0.12% Shares
UBS Group AG $234,254 42,208 0.11% Shares
BANK OF AMERICA CORP /DE/ $209,413 37,732 0.10% Shares
Apella Capital, LLC $201,533 42,250 0.09% Shares
WELLS FARGO & COMPANY/MN $167,993 30,269 0.08% Shares
RHUMBLINE ADVISERS $165,755 29,867 0.08% Shares
TWO SIGMA INVESTMENTS, LP $142,496 25,675 0.07% Shares
Bank of New York Mellon Corp $128,388 23,133 0.06% Shares
NEW YORK STATE COMMON RETIREMENT FUND $109,890 19,800 0.05% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $87,013 15,678 0.04% Shares
Vanguard Global Advisers, LLC $85,109 15,335 0.04% Shares
CITIGROUP INC $77,744 14,008 0.04% Shares
JPMORGAN CHASE & CO $76,644 14,115 0.04% Shares
Invesco Ltd. $75,352 13,577 0.03% Shares
Police & Firemen's Retirement System of New Jersey $57,420 10,346 0.03% Shares
BNP PARIBAS FINANCIAL MARKETS $43,806 7,893 0.02% Shares
BARCLAYS PLC $31,402 5,658 0.01% Shares
BlackRock, Inc. $29,765 5,363 0.01% Shares
NORTHERN TRUST CORP $29,515 5,318 0.01% Shares
Tower Research Capital LLC (TRC) $20,407 3,677 0.01% Shares
Legal & General Group Plc $18,426 3,320 0.01% Shares
Ameritas Investment Partners, Inc. $17,150 3,090 0.01% Shares
Russell Investments Group, Ltd. $15,107 2,722 0.01% Shares
MORGAN STANLEY $14,524 2,617 0.01% Shares
VANGUARD GROUP INC $8,032 1,998 0.00% Shares
ROYAL BANK OF CANADA $7,000 1,236 0.00% Shares
CWM, LLC $2,531 420 0.00% Shares
Larson Financial Group LLC $2,220 400 0.00% Shares
Sterling Capital Management LLC $1,643 296 0.00% Shares
SBI Securities Co., Ltd. $1,393 251 0.00% Shares
FMR LLC $1,315 237 0.00% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $555 100 0.00% Shares
DEUTSCHE BANK AG\ $355 64 0.00% Shares
PRICE T ROWE ASSOCIATES INC /MD/ $155 27,921 0.00% Shares
Caitong International Asset Management Co., Ltd $39 7 0.00% Shares

Company insiders 22 insiders · 9 officers · 14 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Remy Luthringer CEO June 3, 2026 A 0 0 $0
Coelho Rogerio Vivaldi President and CEO June 30, 2014 A 41,667 0 0 $0
Frederick W Ahlholm SVP, CFO and Secretary June 3, 2026 A 17,518 0 0 $0
Geoff Race President Oct. 4, 2023 A 51,324 0 0 $0
Richard E. Russell President June 19, 2020 A 33,770 0 0 $0
Joseph H. Reilly SVP & Chief Operating Officer Dec. 14, 2020 M 31,747 0 0 $0
Devin Whittemore Smith SVP and General Counsel Oct. 13, 2020 A 0 0 $0
Jay Saoud SVP and Head of R&D Oct. 13, 2020 A 0 0 $0
Mark S. Levine SVP,General Counsel & Sec. June 1, 2017 M 0 0 0 $0
Inderjit Kaul Director Aug. 3, 2026 A 0 0 $0
David Kupfer Director June 3, 2026 A 0 0 $0
Fouzia Laghrissi-Thode Director June 3, 2026 A 0 0 $0
HASLER HANS PETER Director June 3, 2026 A 10,000 0 0 $0
VAN HEEK G JAN Director June 3, 2026 A 20,333 0 0 $0
Jeryl L Hilleman Director Sept. 27, 2023 A 1,000 0 0 $0
William F Doyle Director June 10, 2022 A 26,111 0 0 $0
Marc D Beer Director Jan. 31, 2018 A 50,000 0 0 $0
Nico Vandervelpen Director July 24, 2017 A 0 0 $0
De Rubertis Francesco Director Dec. 12, 2016 X 4,690,906 0 0 $0
Michele Ollier Director Dec. 12, 2016 X 4,690,906 0 0 $0
Lorenzo Pellegrini Director July 7, 2014 C 3,883,212 0 0 $0
Michael Davidson Oct. 13, 2020 A 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Boehringer AG, Boehringer Ingelheim International GmbH ×2 filings Dec. 30, 2025 3.40% Amendment SEC
INDEX VENTURE ASSOCIATES III LIMITED, INDEX VENTURES III (JERSEY) L.P., INDEX VENTURES III (DELAWARE) L.P., INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES IV LIMITED, INDEX VENTURES IV (JERSEY) L.P., INDEX VENTURES IV PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES V LIMITED, INDEX VENTURES V (JERSEY) L.P., INDEX VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., YUCCA (JERSEY) SLP ×5 filings June 18, 2019 Initial filing Passive investment SEC
Care Capital Investments III L.P., Care Capital Offshore Investments III LP, Care Capital III LLC ×5 filings May 5, 2016 Initial filing SEC
Care Capital III LLC, Care Capital Investments III LP, Care Capital Offshore Investments III LP July 18, 2014 Initial filing Passive investment SEC
Remy Luthringer, Wint2felden Holding SA July 17, 2014 Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 11 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS July 15, 2026 Daily
VTI · VANGUARD INDEX FUNDS July 15, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS July 15, 2026 Daily
IWN · iShares Trust Aug. 17, 2026 Daily
IWO · iShares Trust Aug. 18, 2026 Daily
IWM · iShares Trust Aug. 18, 2026 Daily
IWC · iShares Trust Aug. 18, 2026 Daily
QQQS · Invesco Exchange-Traded Fund Trust … July 20, 2026 Daily